Alector to present data on pipeline focus areas at the alzheimer's association international conference® (aaic®) 2024

South san francisco, calif., july 23, 2024 (globe newswire) -- alector, inc. (nasdaq: alec), a clinical-stage biotechnology company pioneering immuno-neurology, today announced presentations related to the company's trem2 and progranulin programs at the upcoming alzheimer's association international conference® 2024 (aaic®) being held online and in philadelphia, pennsylvania from july 28 – august 1, 2024.
ALEC Ratings Summary
ALEC Quant Ranking